VeriSIM Life

BiotechnologySeries ASan Francisco, USverisimlife.com

Latest round

Series A

Last raised

Jan 2022

Total raised

$22M

Investors

11

About VeriSIM Life

Founded in 2017, VeriSIM Life is based in San Francisco, US, and focuses on revolutionizing drug development through its BIOiSIM platform. Jo Varshney, the founder and CEO, has a history of leading innovative companies.VeriSIM Life specializes in AI-driven drug discovery and development, offering solutions that improve the efficiency and accuracy of transitioning drug candidates into clinical trials. The BIOiSIM platform features an inferential search space of 1 billion drug-like compounds and utilizes advanced generative AI and deep learning techniques.VeriSIM Life generates revenue through subscription-based services and strategic partnerships within the pharmaceutical and biotechnology sectors. Clients gain access to the BIOiSIM platform and its services through these subscriptions, which enable the use of advanced AI in drug discovery and clinical trial simulations.VeriSIM Life plans to expand its product offerings and enhance its services in the drug discovery space. Specific geographic areas for expansion have not been detailed yet, but this growth is anticipated to occur within the next two years.

Who invested in VeriSIM Life

11 investors across 2 rounds

See all investors in VeriSIM Life

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 6, 2022

    Amount

    $15M

    Investors

    Locked

  2. Seed

    Jul 31, 2019

    Amount

    $6.5M

    Investors

    Locked

Questions about VeriSIM Life

Who invested in VeriSIM Life?

VeriSIM Life has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has VeriSIM Life raised?

VeriSIM Life has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did VeriSIM Life last raise money?

VeriSIM Life's most recent round on record is a Series A, in Jan 2022.

What does VeriSIM Life do?

Founded in 2017, VeriSIM Life is based in San Francisco, US, and focuses on revolutionizing drug development through its BIOiSIM platform.

Where is VeriSIM Life headquartered?

VeriSIM Life is headquartered in San Francisco, US.

Which VCs invest in companies like VeriSIM Life?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at VeriSIM Life's stage. Their profiles are linked below.

Raising like VeriSIM Life? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.